Molecular targets for selenium in cancer prevention

Nutrition and Cancer

Volumn 40, Issue 1, 2001, Pages 50-54

  Kim, Y S ^a   Milner, J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SELENITE; SELENIUM DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; DIET; DISEASE ACTIVITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; REVIEW;

EID: 0035678698     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC401_10     Document Type: Review

References (66)

1. Prevention of exudative diathesis in chicks by factor 3 and selenium
2. Selenium and fertility in animals and man - A review
3. The diverse role of selenium within selenoproteins: A review
4. Selenium and cardiovascular diseases - An update
5. Effects of dietary antioxidants on the immune function of middle-aged adults
6. Dietary oxidative stress and the potentiation of viral infection
7. Possible protective effect of selenium against human cancer
8. Interpretation of the methylene blue reduction test of human plasma and the possible cancer-protecting effect of selenium
9. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
10. Inhibition of chemical carcinogenesis and tumorigenesis by selenium
11. Selenium: Mechanistic aspects of anticarcinogenic action
12. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
13. Factors influencing the inhibitory effect of selenium on mice inoculated with Ehrlich ascites tumor cells
14. Inhibitory effects of selenium on the growth of L1210 leukemic cells
15. Inhibition of human breast cancer cells by selenium
16. Effect of selenium on the growth of three human colon cancer cell lines
17. Dissociation of the genotoxic and growth inhibitory effects of selenium
18. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines
19. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate
20. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention
21. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line
22. Effects of organic and inorganic selenium compounds on rat mammary tumor cells
23. Inhibition of PKC and PKA by chemopreventive organoselenium compounds
24. Influence of intracellular glutathione on selenite-mediated growth inhibition of canine mammary tumor cells
25. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione
26. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: Its role in inhibition of tumor promotion
27. Free radical generation by selenium compounds and their prooxidant toxicity
28. Studies on the inhibition of protein synthesis by selenodiglutathione
29. Factors influencing the antitumorigenic properties of selenium in mice
30. Induction of apoptosis by selenite and selenodiglutathione in HL-60 cells: Correlation with cytotoxicity
31. Chemical form of selenium, critical metabolites, and cancer prevention
32. In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
33. Control of lκ B-α proteolysis by site-specific, signal-induced phosphorylation
34. The NF-κ B and IκB proteins: New discoveries and insights
35. Function and activation of NF-κB in the immune system
36. Redox regulation of NF-κB activation
37. Activator protein 1 (AP-1) and nuclear factor-κB (NF-κB)-dependent transcriptional events in carcinogenesis
38. Oxidative stress and nuclear factor-κB activation: A reassessment of the evidence in the light of recent discoveries
39. Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: Effect of selenium supplementation
40. Inhibition of IκB-α phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression
41. Interleukin-1-induced nuclear factor-κB activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line
42. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations
43. Thioredoxin and thioredoxin reductase
44. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases
45. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62
46. Effect of selenium on rat thioredoxin reductase activity: Increase by supranutritional selenium and decrease by selenium deficiency
47. Cellular thioredoxin reductase activity is regulated by selenium
48. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells
49. Differential induction of growth arrest inducible genes by selenium compounds
50. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells
51. p53, the cellular gatekeeper for growth and division
52. A p53-dependent mouse spindle checkpoint
53. 2/M cell cycle checkpoint
54. Abnormal centrosome amplification in the absence of p53
55. Apoptosis in cancer: Cause and cure
56. Role of p53 family members in apoptosis
57. Selenium causes growth inhibition and apoptosis in human brain tumor cell lines
58. In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity, and apoptosis
59. Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells
60. Tissue-specific functions of individual glutathione peroxidases
61. Regulation of cyclooxygenase and 12-lipoxygenase catalysis by phospholipid hydroperoxide glutathione peroxidase in A431 cells
62. Cytokine-induced regulation of 15-lipoxygenase and phospholipid hydroperoxide glutathione peroxidase in mammalian cells
63. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells
64. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
65. Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone
66. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada